dc.contributor.author | Karabcoglu, Metin | |
dc.contributor.author | Yildiz, Bilal | |
dc.contributor.author | Ucsel, Raif | |
dc.contributor.author | Aydinli, Nur | |
dc.contributor.author | Uzel, Nedret | |
dc.contributor.author | Citak, Agop | |
dc.date.accessioned | 2021-03-05T12:33:48Z | |
dc.date.available | 2021-03-05T12:33:48Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Yildiz B., Citak A., Ucsel R., Karabcoglu M., Aydinli N., Uzel N., "Lidocaine treatment in pediatric convulsive status epilepticus", PEDIATRICS INTERNATIONAL, cilt.50, ss.35-39, 2008 | |
dc.identifier.issn | 1328-8067 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_adcbc064-19f8-42c9-b072-fa0115af5c9a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/115950 | |
dc.identifier.uri | https://doi.org/10.1111/j.1442-200x.2007.02510.x | |
dc.description.abstract | Backgound: Convulsive status epilepticus (CSE) may end fatally or leave serious sequelae. CSE treatment, invariably an emergency case, is based upon i.v. benzodiazepines as well as phenytoin, barbiturates or both. The present paper reports efficiency of lidocaine in CSE. | |
dc.language.iso | eng | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | PEDİATRİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | Lidocaine treatment in pediatric convulsive status epilepticus | |
dc.type | Makale | |
dc.relation.journal | PEDIATRICS INTERNATIONAL | |
dc.contributor.department | Eskişehir Osmangazi Üniversitesi , , | |
dc.identifier.volume | 50 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 35 | |
dc.identifier.endpage | 39 | |
dc.contributor.firstauthorID | 186477 | |